Orchid Pharma Limited (NSE: ORCHPHARMA), ISIN INE191A01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ORCHPHARMA last traded at ₹984.35 (-1.73%), with a 52-week range of ₹471.30 to ₹1120.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 69.84%, FIIs 0.81%, DIIs 20.75%, mutual funds 19.93%.
EquiSense Score (ECS): 77/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.